chr15-72736824-C-CT
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_033028.5(BBS4):c.1311_1312insT(p.Lys438fs) variant causes a frameshift, stop gained change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_033028.5 frameshift, stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBS4 | NM_033028.5 | c.1311_1312insT | p.Lys438fs | frameshift_variant, stop_gained | Exon 15 of 16 | ENST00000268057.9 | NP_149017.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
BBS4-related disorder Pathogenic:1
The BBS4 c.1311_1312insT variant is predicted to result in premature protein termination (p.Lys438*). This variant was reported in the compound heterozygous state in an individual with retinal dystrophy (Supplementary data in Patel et al 2016. PubMed ID: 26355662). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in BBS4 are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
Bardet-Biedl syndrome 4 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at